# Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma

> clinical trial · VERIFIED · 2026-08-03

Status: RECRUITING · Sponsor: Xencor, Inc. · Condition: Clear Cell Renal Cell Carcinoma

- Company: Xencor, Inc.
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05433142

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.